226
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: An updated meta-analysis

, , , , , , , , , , , & show all
Pages 453-461 | Received 16 Jul 2014, Accepted 03 Oct 2014, Published online: 17 Nov 2014

References

  • Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10(1):R17.
  • Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998;41(1):58–67.
  • Brown MA. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford). 2008;47(2):132–7.
  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1(7809):904–7.
  • Kim TJ, Na KS, Lee HJ, Lee B, Kim TH. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol. 2009;27(4):574–9.
  • Jaakkola E, Herzberg I, Laiho K, Barnardo MC, Pointon JJ, Kauppi M, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65(6):775–80.
  • Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40(10):1823–8.
  • Fierabracci A, Milillo A, Locatelli F, Fruci D. The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev. 2012;12(2):281–8.
  • Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001;68(4):918–26.
  • Keidel S, Chen L, Pointon J, Wordsworth P. ERAP1 and ankylosing spondylitis. Curr Opin Immunol. 2013;25(1):97–102.
  • Duan Z, Pan F, Zeng Z, Zhang T, Wang S, Li G, et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int. 2012;32(5):1209–14.
  • Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11(10):763–76.
  • Julia A, Tortosa R, Hernanz JM, Canete JD, Fonseca E, Ferrandiz C, et al. Risk variants for psoriasis vulgaris in a large case–control collection and association with clinical subphenotypes. Hum Mol Genet. 2012;21(20):4549–57.
  • Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202–7.
  • Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009;10(2):188–91.
  • Guerini FR, Cagliani R, Forni D, Agliardi C, Caputo D, Cassinotti A, et al. A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS One. 2012;7(1):e29931.
  • Wellcome Trust Case Control C, Australo-Anglo-American Spondylitis C, Burton PR, Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329–37.
  • Lee YH, Choi SJ, Ji JD, Song GG. Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res. 2011;60(11):999–1003.
  • Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 2009;60(11):3263–8.
  • Zhang Z, Dai D, Yu K, Yuan F, Jin J, Ding L, et al. Association of HLA-B27 and ERAP1 with ankylosing spondylitis susceptibility in Beijing Han Chinese. Tissue Antigens. 2014;83(5):324–9.
  • Wu W, Ding Y, Chen Y, Hua Z, Liu H, Wang H, et al. Susceptibility to ankylosing spondylitis: evidence for the role of ERAP1, TGFb1 and TLR9 gene polymorphisms. Rheumatol Int. 2012; 32(8):2517–21.
  • Ding Y, Chen YZ. Association study of ankylosing spondylitis and polymorphisms in ERAP1 gene, TLR9 gene and TGF β1 gene in Shandong Han population. Shandong Univ. 2010:16–23.
  • Hoaglund FT. Primary osteoarthritis of the hip: a genetic disease caused by European genetic variants. J Bone Joint Surg Am. 2013; 95(5):463–8.
  • Lin Z, Bei JX, Shen M, Li Q, Liao Z, Zhang Y, et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet. 2012;44(1):73–7.
  • Australo-Anglo-American Spondyloarthritis C, Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010;42(2):123–7.
  • Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al.;Australo-Anglo-American Spondyloarthritis Consortium (TASC); Wellcome Trust Case Control Consortium 2 (WTCCC2). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761–7.
  • Chen R, Yao L, Meng T, Xu W. The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls. Rheumatol Int. 2012;32(4):909–14.
  • Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed on 7th June 2014.
  • Zhu ZH, Jin XZ, Zhang W, Chen M, Ye DQ, Zhai Y, et al. Associations between vitamin D receptor gene polymorphisms and osteoarthritis: an updated meta-analysis. Rheumatology (Oxford). 2014;53(6): 998–1008.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
  • Wang CM, Ho HH, Chang SW, Wu YJ, Lin JC, Chang PY, et al. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther. 2012;14(3):R125.
  • Chen C, Wang Y. Association of ERAP1, ANTXR2, IL1R2, IL23R, JAK2 and STAT3 polymorphisms with ankylosing spondylitis. Chin PLA Med. 2010:15–33.
  • Pankaj D, Hu LH. Investigating the association of HLA-B27, IL-23R and ERAP1 polymorphisms in patients with Ankylosing spondylitis in China. Huazhong Univ Sci Technol 2011:22–33.
  • Choi CB, Kim TH, Jun JB, Lee HS, Shim SC, Lee B, et al. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann Rheum Dis. 2010;69(3):582–4.
  • Pazar B, Safrany E, Gergely P, Szanto S, Szekanecz Z, Poor G. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol. 2010;37(2):379–84.
  • Szczypiorska M, Sanchez A, Bartolome N, Arteta D, Sanz J, Brito E, et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford). 2011;50(11):1969–75.
  • Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, Appleton LH, et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet. 2009;18(21):4204–12.
  • Pimentel-Santos FM, Ligeiro D, Matos M, Mourao AF, Sousa E, Pinto P, et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol. 2009; 27(5):800–6.
  • Cinar M, Akar H, Yilmaz S, Simsek I, Karkucak M, Sagkan RI, et al. A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population. Rheumatol Int. 2013;33(11):2851–8.
  • Xia Y, Wang LC, Sun H, Tang HW, Ma CY, Cui B, et al. Association of polymorphisms in the ERAP1 gene with ankylosing spondylitis in the Han Chinese population. J Shandong Univ (Health Sciences). 2011;49(10):127–30.
  • Mahmoudi M, Jamshidi AR, Amirzargar AA, Farhadi E, Nourijelyani K, Fallahi S, et al. Association between endoplasmic reticulum aminopeptidase-1 (ERAP-1) and susceptibility to ankylosing spondylitis in Iran. Iran J Allergy Asthma Immunol. 2012;11(4):294–300.
  • Bang SY, Kim TH, Lee B, Kwon E, Choi SH, Lee KS, et al. Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patients. J Rheumatol. 2011;38(2):322–4.
  • Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum. 2009;60(5):1317–23.
  • Li C, Lin Z, Xie Y, Guo Z, Huang J, Wei Q, et al. ERAP1 is associated with ankylosing spondylitis in Han Chinese. J Rheumatol. 2011;38(2):317–21.
  • Kadi A, Izac B, Said-Nahal R, Leboime A, Van Praet L, de Vlam K, et al. Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis. 2013;72(4):608–13.
  • Zvyagin IV, Dorodnykh VY, Mamedov IZ, Staroverov DB, Bochkova AG, Rebrikov DV, et al. Association of ERAP1 Allelic Variants with Risk of Ankylosing Spondylitis. Acta Naturae. 2010; 2(3):72–7.
  • Cherciu M, Popa LO, Bojinca M, Dutescu MI, Bojinca V, Bara C, Popa OM. Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis. Tissue Antigens. 2013;82(3): 192–6.
  • Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, et al. A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection. 2011;39(1):21–7.
  • Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A. 2011;108(19): 7745–50.
  • Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest. 2002; 110(4):515–26.
  • Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol. 2005;6(7):689–97.
  • Cui X, Rouhani FN, Hawari F, Levine SJ. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol. 2003;171(12):6814–9.
  • Goto Y, Ogawa K, Hattori A, Tsujimoto M. Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-gamma. J Biol Chem. 2011;286(24):21906–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.